ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Non-Small-Cell Lung Carcinoma
Cancer
Fallopian Tube Cancer
Colorectal Cancer

Ovarian Cancer trials near Austin, TX, USA:

Safety in Ovarian Cancer for Average-Risk Women - Analysis (SOARA)

This study is designed to evaluate the safety, specificity, and downstream diagnostic burden of the Evident™ Ovarian Cancer Screeni ...

Not yet enrolling
Ovarian Cancer
Diagnostic Test: Blood-Based Ovarian Cancer Screening Test
Mercy BioAnalytics, Inc.

Austin, Texas, United States and 1 other location

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

Austin, Texas, United States and 46 other locations

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

Austin, Texas, United States and 20 other locations

Recently updated

study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: Topotecan
Drug: Gemcitabine

Phase 3

Genmab
Genmab

Austin, Texas, United States and 176 other locations

Locations recently updated

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

Austin, Texas, United States and 104 other locations

Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as muc...

Enrolling
Ovarian Neoplasms
Peritoneal Cancer
Drug: Bevacizumab
Biological: R-DXd

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Austin, Texas, United States and 10 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

Austin, Texas, United States and 73 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the s...

Enrolling
Primary Peritoneal Cancer
Epithelial Ovarian Cancer
Drug: Mirvetuximab Soravtansine
Drug: Bevacizumab

Phase 2

AbbVie
AbbVie

Austin, Texas, United States and 72 other locations

HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody...

Enrolling
Endometrial Cancer
Ovarian Cancer Metastatic Recurrent
Drug: HWK-007

Phase 1

Whitehawk Therapeutics, Inc.

Austin, Texas, United States and 11 other locations

Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...

Active, not recruiting
Ovarian Neoplasms
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Drug: Dostarlimab-Placebo
Drug: Standard of care

Phase 3

Tesaro
Tesaro

Austin, Texas, United States and 181 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems